Fabi, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 102
AS - Asia 28
EU - Europa 21
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 4
AF - Africa 1
Totale 166
Nazione #
US - Stati Uniti d'America 98
IT - Italia 19
CN - Cina 12
SG - Singapore 8
VN - Vietnam 3
CA - Canada 2
CO - Colombia 2
HK - Hong Kong 2
JP - Giappone 2
EC - Ecuador 1
GB - Regno Unito 1
IE - Irlanda 1
JM - Giamaica 1
MX - Messico 1
MY - Malesia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 156
Città #
Ashburn 17
San Jose 7
Singapore 5
Beijing 3
Los Angeles 3
Naples 3
Orem 3
Santa Clara 3
Bologna 2
Ho Chi Minh City 2
Hong Kong 2
Milan 2
New York 2
Phoenix 2
St Louis 2
Tokyo 2
Afragola 1
Atlanta 1
Baton Rouge 1
Boardman 1
Bremerton 1
Bucaramanga 1
Caracas 1
Chicago 1
Dallas 1
Detroit 1
Dover 1
Dracut 1
Dublin 1
Edinburgh 1
Elk Grove Village 1
Flat Rock 1
Florence 1
Floridablanca 1
Gustavo Adolfo Madero 1
Jackson 1
Kingston 1
Klerksdorp 1
Kuala Lumpur 1
Las Vegas 1
Long Beach 1
Miami 1
Miano 1
North Kansas City 1
Northbrook 1
Omaha 1
Palmdale 1
Philadelphia 1
Phú Thọ 1
Pioraco 1
Reggio Emilia 1
Rome 1
Sacramento 1
Saint-Eustache 1
San Francisco 1
Scarborough 1
Secaucus 1
Shijiazhuang 1
Sioux City 1
Sucúa 1
Windsor Mill 1
Totale 105
Nome #
Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors) 53
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer 49
HER2 intratumoral heterogeneity predicts response to neoadjuvant therapy in HER2-positive breast cancer: impact and interplay with HER3 expression 11
Real life outcome analysis of breast cancer brain metastases treated with Trastuzumab Deruxtecan 11
The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study 9
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective Study 9
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 9
Predictive risk factors of recurrence in breast cancer after neoadjuvant treatment: the NEORISK study 8
Pregnancy vs. Postpartum Breast Cancer: Distinct Tumor Biology and Survival Trends in a Contemporary Cohort 7
Totale 166
Categoria #
all - tutte 990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/202670 0 0 0 0 0 8 4 6 9 8 2 33
2026/202796 13 43 40 0 0 0 0 0 0 0 0 0
Totale 166